33 related articles for article (PubMed ID: 30903695)
1. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
[TBL] [Abstract][Full Text] [Related]
2. Changes of plasma cGP/IGF-1 molar ratio with age is associated with cognitive status of Parkinson disease.
Fan D; Pitcher T; Dalrymple-Alford J; MacAskill M; Anderson T; Guan J
Alzheimers Dement (Amst); 2020; 12(1):e12025. PubMed ID: 32671179
[TBL] [Abstract][Full Text] [Related]
3. Association of Insulin-like Growth Factor-1 and Neurofilament Light Chain in Patients with Progressive Supranuclear Palsy.
Dey S; Yelamanchi R; Mullapudi T; Holla VV; Kamble N; Mahale RR; Sathyaprabha TN; Pal PK; Debnath M; Yadav R
Ann Indian Acad Neurol; 2024; 27(1):40-45. PubMed ID: 38495245
[TBL] [Abstract][Full Text] [Related]
4. Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies.
Zaichick S; Caraveo G
Front Mol Biosci; 2023; 10():1292555. PubMed ID: 38094080
[No Abstract] [Full Text] [Related]
5. The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers.
Argentati C; Tortorella I; Bazzucchi M; Emiliani C; Morena F; Martino S
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32899957
[TBL] [Abstract][Full Text] [Related]
6. Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.
Zeng HM; Han HB; Zhang QF; Bai H
Neural Regen Res; 2021 Jan; 16(1):73-79. PubMed ID: 32788450
[TBL] [Abstract][Full Text] [Related]
7. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes.
Zhang W; Zhou M; Lu W; Gong J; Gao F; Li Y; Xu X; Lin Y; Zhang X; Ding L; Zhang Z; Li G; Chen X; Sun X; Zhu X; Xu P; Zhang Y
Theranostics; 2020; 10(7):3000-3021. PubMed ID: 32194851
[No Abstract] [Full Text] [Related]
8. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
Bassil F; Fernagut PO; Bezard E; Meissner WG
Prog Neurobiol; 2014 Jul; 118():1-18. PubMed ID: 24582776
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
Nikolaus S; Antke C; Müller HW
Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor-1 levels in neurodegenerative diseases.
Suzuki K; Suzuki S; Ishii Y; Fujita H; Matsubara T; Okamura M; Sakuramoto H; Hirata K
Acta Neurol Scand; 2019 Jun; 139(6):563-567. PubMed ID: 30903695
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
12. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
